These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24180399)

  • 1. Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants?
    Vidal R; Castro E; Pilar-Cuéllar F; Pascual-Brazo J; Díaz A; Rojo ML; Linge R; Martín A; Valdizán EM; Pazos A
    Curr Pharm Des; 2014; 20(23):3751-62. PubMed ID: 24180399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating the promise of 5HT
    Murphy SE; de Cates AN; Gillespie AL; Godlewska BR; Scaife JC; Wright LC; Cowen PJ; Harmer CJ
    Psychol Med; 2021 May; 51(7):1111-1120. PubMed ID: 32241310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways.
    Vidal R; Pilar-Cuéllar F; dos Anjos S; Linge R; Treceño B; Vargas VI; Rodriguez-Gaztelumendi A; Mostany R; Castro E; Diaz A; Valdizán EM; Pazos A
    Curr Pharm Des; 2011; 17(5):521-33. PubMed ID: 21375480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.
    Lucas G; Rymar VV; Du J; Mnie-Filali O; Bisgaard C; Manta S; Lambas-Senas L; Wiborg O; Haddjeri N; Piñeyro G; Sadikot AF; Debonnel G
    Neuron; 2007 Sep; 55(5):712-25. PubMed ID: 17785179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CK2 regulates 5-HT4 receptor signaling and modulates depressive-like behavior.
    Castello J; LeFrancois B; Flajolet M; Greengard P; Friedman E; Rebholz H
    Mol Psychiatry; 2018 Apr; 23(4):872-882. PubMed ID: 29158580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A silver bullet for the treatment of depression?
    Duman RS
    Neuron; 2007 Sep; 55(5):679-81. PubMed ID: 17785173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.
    Samuels BA; Mendez-David I; Faye C; David SA; Pierz KA; Gardier AM; Hen R; David DJ
    Neuroscientist; 2016 Feb; 22(1):26-45. PubMed ID: 25488850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 4 receptor (5-HT4R) internalization is isoform-specific: effects of 5-HT and RS67333 on isoforms A and B.
    Mnie-Filali O; Amraei MG; Benmbarek S; Archer-Lahlou E; Peñas-Cazorla R; Vilaró MT; Boye SM; Piñeyro G
    Cell Signal; 2010 Mar; 22(3):501-9. PubMed ID: 19922792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of serotonin neurotransmission in rapid antidepressant actions.
    Pehrson AL; Roberts D; Khawaja A; McNair R
    Psychopharmacology (Berl); 2022 Jun; 239(6):1823-1838. PubMed ID: 35333951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hypothesis of monoamine (5-HT) - Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery.
    Li YF
    Pharmacol Ther; 2020 Apr; 208():107494. PubMed ID: 31991195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin receptors, type 4: a new hope?
    Lucas G
    Curr Drug Targets; 2009 Nov; 10(11):1085-95. PubMed ID: 19702554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic 5-HT4 receptor agonist treatment restores learning and memory deficits in a neuroendocrine mouse model of anxiety/depression.
    Darcet F; Gardier AM; David DJ; Guilloux JP
    Neurosci Lett; 2016 Mar; 616():197-203. PubMed ID: 26850572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors.
    Wang L; Zhang Y; Du X; Ding T; Gong W; Liu F
    Biomed Pharmacother; 2019 Dec; 120():109408. PubMed ID: 31541883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.
    Köhler S; Cierpinsky K; Kronenberg G; Adli M
    J Psychopharmacol; 2016 Jan; 30(1):13-22. PubMed ID: 26464458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut.
    Agrawal L; Korkutata M; Vimal SK; Yadav MK; Bhattacharyya S; Shiga T
    Neuropharmacology; 2020 Apr; 166():107969. PubMed ID: 31982703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT(4) receptors, a place in the sun: act two.
    Bockaert J; Claeysen S; Compan V; Dumuis A
    Curr Opin Pharmacol; 2011 Feb; 11(1):87-93. PubMed ID: 21342787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peptidic antidepressant spadin interacts with prefrontal 5-HT(4) and mGluR(2) receptors in the control of serotonergic function.
    Moha ou Maati H; Bourcier-Lucas C; Veyssiere J; Kanzari A; Heurteaux C; Borsotto M; Haddjeri N; Lucas G
    Brain Struct Funct; 2016 Jan; 221(1):21-37. PubMed ID: 25233810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying fast-onset antidepressants using rodent models.
    Ramaker MJ; Dulawa SC
    Mol Psychiatry; 2017 May; 22(5):656-665. PubMed ID: 28322276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.